Alvotech (ALVO) stock
ALVONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ALVOW
$4.37−0.04 (-0.79%)
Close on Nov 17, 2026Market cap $1.36BP/E 43.7Yield –
Alvotech total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Alvotech's total debt was $1.31B at Jun 30, 2026. For fiscal 2025 it was $1.30B, up 21.6% from the year before. The highest annual figure on record is $1.30B in fiscal 2025.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.30B | +21.6% |
| FY2024 | Dec 31, 2024 | $1.07B | +11.3% |
| FY2023 | Dec 31, 2023 | $960.16M | +22.4% |
| FY2022 | Dec 31, 2022 | $784.49M | +95.7% |
| FY2021 | Dec 31, 2021 | $400.91M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.31B | +23.7% |
| Q4 FY2025 | Dec 31, 2025 | $1.30B | +35.3% |
| Q2 FY2025 | Jun 30, 2025 | $1.12B | +42.2% |
| Q4 FY2024 | Dec 31, 2024 | $1.07B | +36.2% |
| Q2 FY2024 | Jun 30, 2024 | $1.06B | +163.4% |
| Q4 FY2023 | Dec 31, 2023 | $960.16M | – |
| Q2 FY2023 | Jun 30, 2023 | $786.18M | – |
| Q4 FY2022 | Dec 31, 2022 | $784.49M | – |
| Q4 FY2021 | Dec 31, 2021 | $400.91M | – |
See a number that looks wrong?